Validation of an anti-α-Gal IgE fluoroenzyme-immunoassay for the screening of patients at risk of severe anaphylaxis to cetuximab

BACKGROUND: The link between immediate hypersensitivity reactions (HSR) following the first cetuximab infusion and the IgE sensitization against anti-galactose-α-1,3-galactose (α-Gal) is now well-established. An automated Fluoroenzyme-Immunoassay (FEIA) is available and may facilitate the screening...

Descripción completa

Detalles Bibliográficos
Autores principales: Serrier, Julien, Davy, Jean-Baptiste, Dupont, Benoît, Clarisse, Bénédicte, Parienti, Jean-Jacques, Petit, Gautier, Khoy, Kathy, Ollivier, Yann, Gervais, Radj, Mariotte, Delphine, Le Mauff, Brigitte
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9827640/
https://www.ncbi.nlm.nih.gov/pubmed/36624467
http://dx.doi.org/10.1186/s12885-023-10501-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9827640/
https://www.ncbi.nlm.nih.gov/pubmed/36624467
http://dx.doi.org/10.1186/s12885-023-10501-5

Ejemplares similares